Safety and efficacy of R21/Matrix-M vaccine against and eradicate malaria infection
DOI:
https://doi.org/10.35335/midwifery.v12i2.1595Keywords:
Malaria, Vaksin R21/Matrix-M, Vaksin MalariaAbstract
Malaria continues to be a substantial health concern, characterised by elevated rates of illness and death. The development of resistance to existing treatments poses unique obstacles to infection control initiatives. To combat the increasing incidence of malaria, it is imperative to create malaria vaccines such as RTS,S/AS01 and R21/Matrix-M. This study conducted a systematic literature revieew to evaluate the safety and efficacy of malaria vaccines that are currently being developed, with a specific focus on the R21/Matrix-M vaccine. Applying the PRISMA criteria, we identified five studies that specifically examined the efficacy and safety of the R21/Matrix-M vaccination. The findings indicated that the R21/Matrix-M vaccine exhibits favourable tolerability and demonstrates substantial efficacy in clinical studies. Nevertheless, the scarcity of research on the R21/Matrix-M vaccine thus far emphasises the necessity for additional investigation to substantiate its efficacy in malaria treatment.
Downloads
References
Burhanuddin, A. I., Massi, M. N., Thahir, H., Razak, A., & Surungan, T. (2020). Merajut Asa Di Tengah Pandemi Covid-19 (Pandangan Akademisi UNHAS). Deepublish.
Collins, K. A., Snaith, R., Cottingham, M. G., Gilbert, S. C., & Hill, A. V. S. (2017). Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. Scientific Reports, 7(1), 46621. https://doi.org/10.1038/srep46621
Datoo, M. S. (2022). Developing a new anti-sporozoite malaria vaccine. ethos.bl.uk.
Datoo, M. S., Natama, H. M., Somé, A., Bellamy, D., & ... (2022). Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised …. The Lancet Infectious ….
Datoo, M. S., Natama, H. M., Somé, A., Bellamy, D., Traoré, O., Rouamba, T., Tahita, M. C., Ido, N. F. A., Yameogo, P., Valia, D., Millogo, A., Ouedraogo, F., Soma, R., Sawadogo, S., Sorgho, F., Derra, K., Rouamba, E., Ramos-Lopez, F., Cairns, M., … Tinto, H. (2022a). Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. The Lancet Infectious Diseases, 22(12), 1728–1736. https://doi.org/10.1016/S1473-3099(22)00442-X
Datoo, M. S., Natama, H. M., Somé, A., Bellamy, D., Traoré, O., Rouamba, T., Tahita, M. C., Ido, N. F. A., Yameogo, P., Valia, D., Millogo, A., Ouedraogo, F., Soma, R., Sawadogo, S., Sorgho, F., Derra, K., Rouamba, E., Ramos-Lopez, F., Cairns, M., … Tinto, H. (2022b). Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years’ follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial. The Lancet. Infectious Diseases, 22(12), 1728–1736. https://doi.org/10.1016/S1473-3099(22)00442-X
Datoo, M. S., Natama, M. H., Somé, A., Traoré, O., Rouamba, T., & ... (2021). Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled …. The Lancet.
Datoo, M. S., Natama, M. H., Somé, A., Traoré, O., Rouamba, T., Bellamy, D., Yameogo, P., Valia, D., Tegneri, M., Ouedraogo, F., Soma, R., Sawadogo, S., Sorgho, F., Derra, K., Rouamba, E., Orindi, B., Lopez, F. R., Flaxman, A., Cappuccini, F., … Tinto, H. (2021). Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial. Lancet (London, England), 397(10287), 1809–1818. https://doi.org/10.1016/S0140-6736(21)00943-0
Grant, J., Diawara, H., Traore, S., Koita, F., Myers, J., & ... (2023). Delivery strategies for malaria vaccination in areas with seasonal malaria transmission. BMJ Global ….
Handayani, E. P., Jannah, M., & Rahmawati, A. (2022). Efforts to Increase Pregnant Women’s Knowledge About High-Risk Pregnancy With Health Education. Pharmacology, Medical Reports, Orthopedic, And Illness Details (Comorbid), 1(4), 14–21. https://doi.org/10.55047/comorbid.v1i4.591
Khambali, I., & ST, M. (2019). Pemanasan Global dan Gangguan Kesehatan Serta Mitigasinya. Surabaya: HAKLI Provinsi Jawa Timur.
Khudrotul, U., Ahmad, S., Syahalam, S., Agustiyani, V., Fitri L, T., & Wati, S. (2021). Sikap Masyarakat Mengenai Vaksinani Covid-19.
Kinansi, R. R., Mayasari, R., & Sitorus, H. (2021). Malaria pada kelompok wanita usia subur dan anak di Indonesia: analisis data Riskesdas 2013. Jurnal Vektor Penyakit, 15(1), 17–32.
Kolik, M. (2023). Efektifitas Vaksin Koksivet Iradiasi Terhadap Pencegahan Koksidiosis Sekum Pada Ayam Pedaging Ditinjau Dari Tingkat Kematian Dan Gambaran Darah (Kadar Hemoglobin Dan Nilai Hematokrit). UNIVERSITAS AIRLANGGA.
Melindah, M. (2023). Gambaran Program Pencegahan Dan Pengendalian Malaria Di Provinsi Jawa Timur Tahun 2023. Universitas Airlangga.
Merle, C. S., Badiane, N. A., Affoukou, C. D., Affo, S. Y., Djogbenou, S. L., Hounto, A., Kompaore, S. C. B., Ouedraogo, I., Ateba, M. J., Njoh, A. A., Bomba, D., Tchokfe, S. N., Ali, I. M., Camara, F., Mbodj, M., Sosler, S., Rono, J., Noonan, L., Venu, M., … group, R.-S. working. (2023). Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report. Malaria Journal, 22(1), 242. https://doi.org/10.1186/s12936-023-04657-5
Ningtyas, R., Martini, M., Wurjanto, M. A., & Hestiningsih, R. (2023). Analisis Faktor Risiko Kejadian Malaria pada Anak (Usia 0-18 Tahun) di Kabupaten Purworejo. Jurnal Riset Kesehatan Masyarakat, 3(2), 59–70.
Nitika, N., Nema, S., & Bharti, P. K. (2023). R21 vaccine: A ray of hope for malaria elimination. Asian Pacific Journal of Tropical ….
Novita, S. (2023). Malaria dan Filariasis. CV. EUREKA MEDIA AKSARA.
Parums, D. V. (2023). Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030. In Medical Science Monitor: International Medical Journal of Experimental and Clinical Research (Vol. 29, p. e939357). https://doi.org/10.12659/MSM.939357
Parums, D. V. (2022). Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030. … Science Monitor: International Medical Journal of ….
Pujianto, B. (2022). ANALISA FAKTOR PREDISPOSISI YANG MEMENGARUHI KEIKUTSERTAAN VAKSINASI COVID-19 PADA MASYARAKAT DI KABUPATEN LAMPUNG TENGAH TAHUN 2022. UNIVERSITAS LAMPUNG.
Setiarto, R. H. B., & Karo, M. S. D. M. B. (2021). Pengantar Kuliah Mikrobiologi Klinis. GUEPEDIA.
Shinta, S., & Manalu, H. S. P. (2022). Konflik Sosial dan Pengendalian Malaria Pada Masa Pandemi Covid-19 di Kabupaten Purworejo, Jawa Tengah Tahun 2021. Jurnal Kesehatan Lingkungan Indonesia, 21(3), 274–284.
Simanjorang, C. (2020). INSIDEN KEKAMBUHAN MALARIA VIVAX DI PUSKESMAS DOSAY SENTANI JAYAPURA. Jurnal Ilmiah Sesebanua, 4(2), 50–56.
